                         SEQUENCE LISTING

<110>  ASTUTE MEDICAL, INC.
 
<120>  METHODS AND COMPOSITIONS FOR EVALUATION AND TREATMENT OF RENAL 
       INJURY AND RENAL FAILURE BASED ON C-C MOTIF CHEMOKINE LIGAND 14 
       MEASUREMENT IN COMBINATION WITH ADDITIONAL MARKERS

<130>  A105893 1590WO / 01962 PCT

<150>  62/852,961
<151>  2019-05-24

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  93
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Swiss-Prot Q16627

<400>  1

Met Lys Ile Ser Val Ala Ala Ile Pro Phe Phe Leu Leu Ile Thr Ile 
1               5                   10                  15      


Ala Leu Gly Thr Lys Thr Glu Ser Ser Ser Arg Gly Pro Tyr His Pro 
            20                  25                  30          


Ser Glu Cys Cys Phe Thr Tyr Thr Thr Tyr Lys Ile Pro Arg Gln Arg 
        35                  40                  45              


Ile Met Asp Tyr Tyr Glu Thr Asn Ser Gln Cys Ser Lys Pro Gly Ile 
    50                  55                  60                  


Val Phe Ile Thr Lys Arg Gly His Ser Val Cys Thr Asn Pro Ser Asp 
65                  70                  75                  80  


Lys Trp Val Gln Asp Tyr Ile Lys Asp Met Lys Glu Asn 
                85                  90              


<210>  2
<211>  109
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  C-C motif chemokine 14 isoform 2

<400>  2

Met Lys Ile Ser Val Ala Ala Ile Pro Phe Phe Leu Leu Ile Thr Ile 
1               5                   10                  15      


Ala Leu Gly Thr Lys Thr Glu Ser Ser Ser Gln Thr Gly Gly Lys Pro 
            20                  25                  30          


Lys Val Val Lys Ile Gln Leu Lys Leu Val Gly Gly Pro Tyr His Pro 
        35                  40                  45              


Ser Glu Cys Cys Phe Thr Tyr Thr Thr Tyr Lys Ile Pro Arg Gln Arg 
    50                  55                  60                  


Ile Met Asp Tyr Tyr Glu Thr Asn Ser Gln Cys Ser Lys Pro Gly Ile 
65                  70                  75                  80  


Val Phe Ile Thr Lys Arg Gly His Ser Val Cys Thr Asn Pro Ser Asp 
                85                  90                  95      


Lys Trp Val Gln Asp Tyr Ile Lys Asp Met Lys Glu Asn 
            100                 105                 


